Di Xiangjie, Liang Xiao, Shen Chao, Pei Yuwen, Wu Bin, He Zhiyao
Department of Pharmacy, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Chengdu 610041, China.
Pharmaceutics. 2022 Mar 29;14(4):739. doi: 10.3390/pharmaceutics14040739.
Carbohydrates, one of the most important compounds in living organisms, perform numerous roles, including those associated with the extracellular matrix, energy-related compounds, and information. Of these, polymeric carbohydrates are a class of substance with a long history in drug delivery that have attracted more attention in recent years. Because polymeric carbohydrates have the advantages of nontoxicity, biocompatibility, and biodegradability, they can be used in drug targeting, sustained drug release, immune antigens and adjuvants. In this review, various carbohydrate-based or carbohydrate-modified drug delivery systems and their applications in disease therapy have been surveyed. Specifically, this review focuses on the fundamental understanding of carbohydrate-based drug delivery systems, strategies for application, and the evaluation of biological activity. Future perspectives, including opportunities and challenges in this field, are also discussed.
碳水化合物是生物体内最重要的化合物之一,具有多种功能,包括与细胞外基质、能量相关化合物以及信息传递相关的功能。其中,聚合碳水化合物是一类在药物递送领域有着悠久历史的物质,近年来受到了更多关注。由于聚合碳水化合物具有无毒、生物相容性和可生物降解性等优点,它们可用于药物靶向、药物缓释、免疫抗原和佐剂。在这篇综述中,我们对各种基于碳水化合物或碳水化合物修饰的药物递送系统及其在疾病治疗中的应用进行了综述。具体而言,本综述重点关注对基于碳水化合物的药物递送系统的基本理解、应用策略以及生物活性评估。同时,也讨论了该领域的未来前景,包括机遇和挑战。